We are live on ! Find out more
ACP

Aveo Capital Partners Portfolio holdings

AUM $601M
1-Year Est. Return 5.92%
This Fund
S&P 500
This Quarter Est. Return
+2.36%
1 Year Est. Return
+5.92%
3 Year Est. Return
+19.07%
5 Year Est. Return
+62.74%
10 Year Est. Return
AUM
$224M
AUM Growth
-$2.92M
Cap. Flow
+$1.7M
Cap. Flow %
0.76%
Top 10 Hldgs %
51.28%
Holding
161
New
21
Increased
49
Reduced
61
Closed
21
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCJ icon
126
iShares MSCI Japan Small-Cap ETF
SCJ
$266M
$212K 0.09%
+2,913
New +$222K
SPYG icon
127
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.3B
$212K 0.09%
+5,906
New +$219K
MDY icon
128
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.9B
$211K 0.09%
+622
New +$228K
UNH icon
129
UnitedHealth
UNH
$340B
$211K 0.09%
803
-134
-14% -$34.9K
EFG icon
130
iShares MSCI EAFE Growth ETF
EFG
$16.5B
$210K 0.09%
+2,848
New +$227K
GDX icon
131
VanEck Gold Miners ETF
GDX
$28.8B
$208K 0.09%
10,494
-450
-4% -$8.98K
SRCI
132
DELISTED
SRC Energy Inc
SRCI
$207K 0.09%
+25,000
New +$249K
CSCO icon
133
Cisco
CSCO
$434B
$203K 0.09%
+4,426
New +$199K
PWB icon
134
Invesco Large Cap Growth ETF
PWB
$2.49B
$203K 0.09%
4,489
-315
-7% -$14.8K
LMT icon
135
Lockheed Martin
LMT
$123B
$201K 0.09%
+614
New +$198K
XLK icon
136
State Street Technology Select Sector SPDR ETF
XLK
$122B
$200K 0.09%
5,680
-144
-2% -$5.28K
VRDN icon
137
Viridian Therapeutics
VRDN
$2.48B
$77K 0.03%
1,115
ORKA
138
Oruka Therapeutics
ORKA
$6.28B
$58K 0.03%
432
RAD
139
DELISTED
Rite Aid Corporation
RAD
$21K 0.01%
1,000
SGYP
140
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$14K 0.01%
10,000
ABBV icon
141
AbbVie
ABBV
$464B
-2,523
Closed -$234K
AGZ icon
142
iShares Agency Bond ETF
AGZ
$634M
-2,292
Closed -$255K
AVGO icon
143
Broadcom
AVGO
$1.67T
-83,420
Closed -$2.02M
C icon
144
Citigroup
C
$223B
-3,385
Closed -$227K
HD icon
145
Home Depot
HD
$302B
-1,128
Closed -$220K
IBM icon
146
IBM
IBM
$225B
-1,656
Closed -$221K
IGIB icon
147
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
-3,902
Closed -$207K
IWM icon
148
iShares Russell 2000 ETF
IWM
$77.2B
-2,037
Closed -$334K
IXN icon
149
iShares Global Tech ETF
IXN
$9.43B
-79,740
Closed -$2.19M
KO icon
150
Coca-Cola
KO
$379B
-5,188
Closed -$228K

Similar funds

Aveo Capital Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Aveo Capital Partners held 161 positions worth $224M, down 1.3% from $227M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Aveo Capital Partners's Q3 2018 filing shows 21 new, 49 increased, 61 reduced and 21 closed positions. Its largest new stake was iShares MSCI Switzerland ETF: 83,770 shares worth $2.76M. The largest sale was State Street SPDR S&P Biotech ETF, an estimated $2.21M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 89% a quarter earlier, followed by Energy and Financials.

  • Aveo Capital Partners's largest Q3 2018 buy was iShares MSCI Switzerland ETF: 83,770 shares worth $2.76M.
  • Aveo Capital Partners added most to First Trust Enhanced Short Maturity ETF in Q3 2018, an estimated $1.14M increase.
  • Aveo Capital Partners's biggest Q3 2018 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $1.9M.
  • Aveo Capital Partners fully exited State Street SPDR S&P Biotech ETF in Q3 2018, selling an estimated $2.21M.
  • Aveo Capital Partners's ten largest holdings make up 51% of its $224M portfolio in Q3 2018.
  • Aveo Capital Partners opened 21 new positions and closed 21 in Q3 2018.
  • Aveo Capital Partners's portfolio value fell 1.3% quarter-over-quarter to $224M.

Based on Aveo Capital Partners's 13F filing for Q3 2018, filed 9 Nov 2018.